Bioprocess Capital Ventures

Investor type

VC

Founded

2006

AUM

$50 M

Location

Russia

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Series B

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 06 December, 2025

Profile

The limited liability company Management Company Bioprocess Capital Partners was established on October 6, 2006 to manage the funds of Russian venture company (RVC). Bioprocess Capital Ventures focused on biomedical and fine chemistry startups.

Industry

Medical Devices Chemicals Biotechnology MedTech HealthTech

Region of investment

Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
HkyOQpz0qM9RYr3u HkyOQpz0qM9RYr3u
HkyOQpz0qM9RYr3u
avatar
HkyOQpz0qM9RYr3u HkyOQpz0qM9RYr3u
HkyOQpz0qM9RYr3u
avatar
HkyOQpz0qM9RYr3u HkyOQpz0qM9RYr3u
HkyOQpz0qM9RYr3u
avatar
HkyOQpz0qM9RYr3u HkyOQpz0qM9RYr3u
HkyOQpz0qM9RYr3u
avatar
HkyOQpz0qM9RYr3u HkyOQpz0qM9RYr3u
HkyOQpz0qM9RYr3u
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Bioprocess Capital Ventures

Bioprocess Capital Ventures is located in Russia.
Bioprocess Capital Ventures was founded in 2006.
Bioprocess Capital Ventures invests in companies and startups in Medical Devices, Chemicals, Biotechnology, MedTech, HealthTech.
Bioprocess Capital Ventures invests in companies and startups in Europe.
Bioprocess Capital Ventures invests in companies and startups at Series B.
Bioprocess Capital Ventures usually invests $1-5 m on average.
Bioprocess Capital Ventures has around $50m assets under management.